1. Home
  2. MMSI vs LLYVA Comparison

MMSI vs LLYVA Comparison

Compare MMSI & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMSI
  • LLYVA
  • Stock Information
  • Founded
  • MMSI 1987
  • LLYVA 1991
  • Country
  • MMSI United States
  • LLYVA United States
  • Employees
  • MMSI N/A
  • LLYVA N/A
  • Industry
  • MMSI Medical/Dental Instruments
  • LLYVA Broadcasting
  • Sector
  • MMSI Health Care
  • LLYVA Industrials
  • Exchange
  • MMSI Nasdaq
  • LLYVA Nasdaq
  • Market Cap
  • MMSI 5.5B
  • LLYVA 6.0B
  • IPO Year
  • MMSI 1990
  • LLYVA N/A
  • Fundamental
  • Price
  • MMSI $90.89
  • LLYVA $67.53
  • Analyst Decision
  • MMSI Buy
  • LLYVA
  • Analyst Count
  • MMSI 9
  • LLYVA 0
  • Target Price
  • MMSI $114.33
  • LLYVA N/A
  • AVG Volume (30 Days)
  • MMSI 850.7K
  • LLYVA 211.7K
  • Earning Date
  • MMSI 04-24-2025
  • LLYVA 01-01-0001
  • Dividend Yield
  • MMSI N/A
  • LLYVA N/A
  • EPS Growth
  • MMSI 25.31
  • LLYVA N/A
  • EPS
  • MMSI 2.03
  • LLYVA N/A
  • Revenue
  • MMSI $1,356,514,000.00
  • LLYVA N/A
  • Revenue This Year
  • MMSI $11.31
  • LLYVA $7.29
  • Revenue Next Year
  • MMSI $6.09
  • LLYVA N/A
  • P/E Ratio
  • MMSI $44.77
  • LLYVA N/A
  • Revenue Growth
  • MMSI 7.88
  • LLYVA N/A
  • 52 Week Low
  • MMSI $70.70
  • LLYVA $32.55
  • 52 Week High
  • MMSI $111.45
  • LLYVA $79.63
  • Technical
  • Relative Strength Index (RSI)
  • MMSI 38.06
  • LLYVA 51.40
  • Support Level
  • MMSI $89.66
  • LLYVA $64.92
  • Resistance Level
  • MMSI $96.27
  • LLYVA $67.99
  • Average True Range (ATR)
  • MMSI 4.86
  • LLYVA 3.53
  • MACD
  • MMSI -0.77
  • LLYVA 0.30
  • Stochastic Oscillator
  • MMSI 24.90
  • LLYVA 67.35

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.

Share on Social Networks: